This study reveals that in people with first episode of psychosis receiving oral antipsychotic medication, switching to long-acting injectable antipsychotic therapy may reduce psychotic relapses, especially in vulnerable subgroups, such as those with prior relapses or non-adherence to antipsychotic medication.
- Alejandro G. Szmulewicz
- Gonzalo Martínez-Alés
- Gabriel Devenyi
